Abstract
Hyperhidrosis is an eccrine sweat gland disease that results from sympathetic hyperactivity, usually occurring on the axilla, palm, sole, or groin. It causes not only cosmetic problems, but also social stress in affected patients. Until now, several modalities have been used to treat focal hyperhidrosis, with variable clinical outcomes and complications, including skin irritation, neurological problems, and nonesthetic scar formation. Botulinum toxin type A has been used widely and successfully in the treatment of hyperhidrosis since 1981. Botulinum toxin type B has recently been introduced for off-label use after being approved by the Food and Drug Administration in 2000 for the treatment of cervical dystonia. However, there has been no report of Botulinum toxin type B treatment for palmoplanar hyperhidrosis in the Koreandermatologic literature. Herein, we report the first case of palmoplanar hyperhidrosis successfully treated with Botulinum Toxin B in Korea, along with a review of the literature.
| Original language | English |
|---|---|
| Pages (from-to) | 447-451 |
| Number of pages | 5 |
| Journal | Korean Journal of Dermatology |
| Volume | 47 |
| Issue number | 4 |
| Publication status | Published - 2009 Apr 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Dermatology
Cite this
}
A case of palmoplanar hyperhidrosis successfully treated with botulinum toxin B. / Park, Jin Mo; Kim, Hee Jung; Kim, Jihyun; Lee, JuHee.
In: Korean Journal of Dermatology, Vol. 47, No. 4, 01.04.2009, p. 447-451.Research output: Contribution to journal › Article
TY - JOUR
T1 - A case of palmoplanar hyperhidrosis successfully treated with botulinum toxin B
AU - Park, Jin Mo
AU - Kim, Hee Jung
AU - Kim, Jihyun
AU - Lee, JuHee
PY - 2009/4/1
Y1 - 2009/4/1
N2 - Hyperhidrosis is an eccrine sweat gland disease that results from sympathetic hyperactivity, usually occurring on the axilla, palm, sole, or groin. It causes not only cosmetic problems, but also social stress in affected patients. Until now, several modalities have been used to treat focal hyperhidrosis, with variable clinical outcomes and complications, including skin irritation, neurological problems, and nonesthetic scar formation. Botulinum toxin type A has been used widely and successfully in the treatment of hyperhidrosis since 1981. Botulinum toxin type B has recently been introduced for off-label use after being approved by the Food and Drug Administration in 2000 for the treatment of cervical dystonia. However, there has been no report of Botulinum toxin type B treatment for palmoplanar hyperhidrosis in the Koreandermatologic literature. Herein, we report the first case of palmoplanar hyperhidrosis successfully treated with Botulinum Toxin B in Korea, along with a review of the literature.
AB - Hyperhidrosis is an eccrine sweat gland disease that results from sympathetic hyperactivity, usually occurring on the axilla, palm, sole, or groin. It causes not only cosmetic problems, but also social stress in affected patients. Until now, several modalities have been used to treat focal hyperhidrosis, with variable clinical outcomes and complications, including skin irritation, neurological problems, and nonesthetic scar formation. Botulinum toxin type A has been used widely and successfully in the treatment of hyperhidrosis since 1981. Botulinum toxin type B has recently been introduced for off-label use after being approved by the Food and Drug Administration in 2000 for the treatment of cervical dystonia. However, there has been no report of Botulinum toxin type B treatment for palmoplanar hyperhidrosis in the Koreandermatologic literature. Herein, we report the first case of palmoplanar hyperhidrosis successfully treated with Botulinum Toxin B in Korea, along with a review of the literature.
UR - http://www.scopus.com/inward/record.url?scp=68949210415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68949210415&partnerID=8YFLogxK
M3 - Article
VL - 47
SP - 447
EP - 451
JO - Korean Journal of Dermatology
JF - Korean Journal of Dermatology
SN - 0494-4739
IS - 4
ER -